A 2026 study of 41 adults with active Crohn’s disease found that 71% successfully consumed their full prescribed dose of a half-nutrition diet (50% medical formula, 50% regular food) every day for six weeks while taking adalimumab medication. According to Gram Research analysis, 93% of patients said they would use this diet again, suggesting partial enteral nutrition is a practical and acceptable dietary option for managing Crohn’s disease alongside medication.
A new study tested whether people with active Crohn’s disease could stick with a special half-nutrition diet while taking the medication adalimumab. Researchers followed 41 adults for six weeks who received half their calories from a medical nutrition drink and ate regular food for the other half. The results were encouraging: 71% of patients drank the full prescribed amount every single day, and 95% met their nutrition goals for at least five weeks. Most importantly, 93% said they’d use this diet again. This suggests that partial enteral nutrition could be a practical dietary option for managing Crohn’s disease alongside medication.
Key Statistics
A 2026 study of 41 adults with active Crohn’s disease found that 71% of patients successfully consumed their full prescribed dose of a half-nutrition diet every day for six weeks while taking adalimumab medication.
In the BIOPIC trial of 41 Crohn’s disease patients, 95% met their full partial enteral nutrition targets for at least five out of six weeks, with a median consumption rate of 96% of the prescribed medical formula.
According to a 2026 study of 41 adults with active Crohn’s disease, 93% of patients reported they would use a half-nutrition diet again to manage their condition, indicating high patient acceptance.
In a 2026 trial of 41 Crohn’s disease patients, only 11.5% reported feeling too full from the medical nutrition component, and 10.5% cited social life constraints as a barrier to adherence with partial enteral nutrition.
The Quick Take
- What they studied: Whether adults with active Crohn’s disease could tolerate and stick with a diet where half their nutrition came from a medical drink and half from regular food, while also taking the drug adalimumab.
- Who participated: 41 adults with active Crohn’s disease who were being treated with adalimumab. The study lasted six weeks and tracked how well patients followed the diet plan.
- Key finding: 71% of patients successfully drank their full prescribed medical nutrition dose every day for six weeks, and 95% met their nutrition targets for at least five weeks. Most patients (93%) said they would use this diet again.
- What it means for you: If you have Crohn’s disease, a half-nutrition diet combined with medication might be easier to follow than stricter dietary approaches. However, talk with your doctor before making any diet changes, as this study was small and results may vary by person.
The Research Details
Researchers recruited 41 adults with active Crohn’s disease who were already taking adalimumab, a common medication for this condition. For six weeks, participants in the treatment group received a special medical nutrition formula that provided exactly half their daily calories, while they ate regular food for the other half. The control group continued taking adalimumab without the special diet.
To measure how well people stuck with the diet, researchers used three different methods: they interviewed patients with a dietitian using a checklist, they analyzed food diaries that patients kept, and they checked how much of the medical formula was actually consumed by weighing bottles and unused stock. This multi-method approach gave researchers confidence in their results.
Researchers also looked at what regular foods people ate by reviewing their food diaries, comparing the diet group to the medication-only group to see if people changed their eating habits.
Using multiple ways to measure adherence (interviews, food diaries, and actual formula consumption) makes the results more reliable. This approach catches whether people say they’re following the diet versus what they actually do. The study also measured real-world acceptability by asking patients directly about their experience, which matters because a diet only works if people can actually stick with it.
This was a small study with 41 participants, which limits how much we can generalize the findings to all Crohn’s disease patients. The study didn’t have a long follow-up period (only six weeks), so we don’t know if people could maintain this diet for months or years. The study was published in a peer-reviewed journal, which means other experts reviewed the methods. However, the small size means results should be confirmed with larger studies before making major treatment recommendations.
What the Results Show
The study found strong evidence that patients could stick with the half-nutrition diet. When researchers counted how many patients drank their full prescribed amount every single day for the entire six weeks, 71% (29 out of 41 patients) succeeded. When they looked at a slightly less strict measure—meeting the full nutrition goal for at least five out of six weeks—95% of patients (39 out of 41) succeeded.
When asked about their experience, 59% of patients reported having no problems at all with the diet. The main complaints were: 11.5% felt too full from the medical drink, 10.5% said it interfered with their social life (like eating out with friends), and 5% got tired of the taste. These numbers show that most people tolerated the diet well.
Perhaps most importantly for real-world use, 93% of patients said they would use this diet again to manage their Crohn’s disease. This high acceptance rate suggests people found it worth doing, even though it required drinking a medical formula daily.
When researchers analyzed food diaries, they found patients actually consumed a median of 96% of the medical formula provided, confirming the interview and questionnaire results. The diet group also naturally modified what they ate during their unrestricted meals, particularly at dinner, suggesting they adapted their eating patterns to accommodate the medical nutrition component.
The study revealed that patients in the diet group made spontaneous changes to their regular meals, especially dinner. This suggests that people naturally adjusted their eating without being told to do so, which could indicate the diet felt manageable enough to integrate into daily life. The fact that patients modified their own diet choices rather than abandoning the program entirely is a positive sign of acceptance.
Previous research has shown that exclusive enteral nutrition (where 100% of calories come from medical formula) works well for Crohn’s disease but is very restrictive and hard for adults to follow. This study supports the idea that partial enteral nutrition (50% medical formula, 50% regular food) offers a middle ground—it provides therapeutic benefits while being more acceptable to patients. The high adherence rates (71-95%) in this study are comparable to or better than what’s been reported for exclusive enteral nutrition in adults, suggesting this approach might be more practical for real-world use.
The study only included 41 patients, which is a small number. Results from small studies may not apply to all people with Crohn’s disease. The study only lasted six weeks, so we don’t know if people could maintain this diet for longer periods. The study didn’t compare the diet group to a control group that didn’t receive the diet, so we can’t say for certain that the diet itself caused any improvements (though the study wasn’t designed to measure disease improvement). The study also didn’t track whether the diet actually improved Crohn’s disease symptoms or inflammation markers, only whether people could stick with it.
The Bottom Line
According to Gram Research analysis, a half-nutrition diet combining medical formula with regular food appears to be well-tolerated and practical for adults with active Crohn’s disease taking adalimumab. The evidence for acceptability is strong (93% would use it again), but evidence for disease improvement is not yet established. Confidence level: Moderate for acceptability; Low for clinical benefit. Always discuss dietary changes with your gastroenterologist and registered dietitian before starting.
Adults with active Crohn’s disease who are already taking adalimumab or similar medications should discuss this option with their doctor. This approach may be particularly helpful for people who find exclusive enteral nutrition too restrictive. People with severe Crohn’s disease, those unable to tolerate medical formulas, or those with swallowing difficulties should consult their healthcare team. This study doesn’t provide evidence for children or people taking different medications.
This study only measured adherence over six weeks, so that’s the timeframe we have data for. Whether benefits persist beyond six weeks is unknown. Most people reported they would continue the diet, but real-world adherence over months or years hasn’t been studied. Expect to work with a dietitian to establish the routine, which typically takes 2-4 weeks.
Frequently Asked Questions
Can I eat regular food while on a Crohn’s disease nutrition treatment?
Yes. A 2026 study of 41 Crohn’s patients found that a half-nutrition approach—where 50% of calories come from medical formula and 50% from regular food—works well with medication. Most patients (93%) found this more acceptable than stricter dietary approaches.
How long can you stick with partial enteral nutrition for Crohn’s disease?
This study tracked patients for six weeks, finding 71% maintained full adherence daily and 95% met targets for at least five weeks. Long-term adherence beyond six weeks hasn’t been studied, so discuss duration with your healthcare team.
What are the main complaints people have about partial enteral nutrition?
In a 2026 study of 41 Crohn’s patients, 59% reported no issues. Among those who did: 11.5% felt too full, 10.5% found it limited their social eating, and 5% experienced taste fatigue with the medical formula.
Does partial enteral nutrition actually improve Crohn’s disease symptoms?
This study measured whether patients could stick with the diet (they could), but didn’t measure whether it improved symptoms or inflammation. Larger studies are needed to confirm clinical benefits beyond acceptability.
Is partial enteral nutrition better than exclusive enteral nutrition for Crohn’s disease?
This study found 71-95% adherence rates for partial enteral nutrition, which appears comparable to or better than exclusive enteral nutrition in adults. The half-nutrition approach allows regular food, making it potentially more practical for long-term use.
Want to Apply This Research?
- Track daily medical formula consumption as a percentage of prescribed amount (target: 100%). Log this each evening along with a simple 1-5 scale rating of how full you felt and any social eating challenges encountered.
- Set a daily reminder for your medical formula intake at the same time each day (e.g., with breakfast). Use the app to log what you ate during your unrestricted meals to identify patterns in what foods work best with your diet plan.
- Weekly review of adherence percentage and symptom notes. Track any changes in Crohn’s symptoms (pain, bathroom frequency, energy level) alongside diet adherence to identify personal patterns. Share monthly summaries with your dietitian to adjust the plan if needed.
This article summarizes research findings and should not replace professional medical advice. Partial enteral nutrition is a medical treatment that requires supervision by a gastroenterologist and registered dietitian. Do not start, stop, or modify any Crohn’s disease treatment or diet without consulting your healthcare provider first. Individual results vary, and this small six-week study may not apply to all patients. This research measures diet acceptability, not disease improvement. Always work with your medical team to develop a treatment plan appropriate for your specific condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.